$6.83 $0.13 per serving
Product analysis
Fish Oil 1200 mg offers marine fats for omega-3 intake, but the separate EPA and DHA amounts are omitted. Those missing amounts make it difficult to judge its contribution to blood-fat support.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The fatty-acid forms are unspecified, so their quality and absorption potential cannot be compared confidently. Total fish-oil weight alone does not identify the individual active fats.
Ingredient Transparency30
Several amounts are listed, but EPA, DHA and the remaining fatty-acid quantities are omitted. Missing forms and composition details prevent a clear picture of the omega-3 mixture.
Value For Money40
Value for the omega-3 contribution remains uncertain. Missing individual EPA and DHA amounts prevent a useful comparison of what you receive for the cost.
Customer Satisfaction86
Customer ratings are very positive across a substantial number of reviews. That provides a broad picture of satisfaction without establishing health benefits.
Product Focus44
The intended uses concern skin and cardiovascular nutrition, but their connection to the declared serving is uncertain. Missing EPA and DHA amounts limit comparison with the preparations linked to blood-fat benefits.
- Format
Softgel - Container
- 100 Softgel(s)
- Per serving
- $0.13
- Also available
Fish Oil 1000 mg$12.00- Customer rating
- 4.8 · 1,665 ratings
Goals
Impact
Situational effect
Fish Oil · 2400 mg
Fish Oil 1200 mg lists fish oil and total omega-3 mass, but no separate EPA or DHA amount for a serving. Without those active amounts, its link to triglyceride support cannot be matched to studied doses, and the disclosed dose shows no meaningful pathway coverage. This concerns lipid markers, not proven heart attack or stroke prevention.
How this product is rated for Cardiovascular Support
Ingredient fit44
The label names fish oil and total omega-3s, but the active EPA and DHA amounts aren't clear. The carrier amount alone cannot show how closely this serving matches cardiovascular marker evidence.
Goal fit
The product centers on fish oil, but carrier and total omega-3 amounts don't show the active EPA/DHA focus.
Dose adequacy
EPA and DHA have no disclosed serving amounts, so their dose match is unknown.
Pathways0
No pathway has a quantified active dose to support a meaningful link. The disclosed amounts don't establish broad coverage of the listed marker areas.
Depth
No listed pathway has a known active dose to support meaningful coverage.
Breadth
The label doesn't establish substantial support across any of the pathway areas.
Evidence0
The supplied human marker evidence concerns EPA and DHA, but neither active is quantified here at a useful amount. No studied active preparation can be matched to this serving.
Evidence strength
Neither EPA nor DHA is quantified at a dose that can be matched to the supplied evidence.
Studied preparation
The serving doesn't show how much of any studied EPA/DHA preparation it provides.
Formulation logic75
EPA and DHA can each contribute to triglyceride markers, and no conflict trigger is identified. Their serving amounts remain unknown.
Partner coverage
EPA and DHA can work individually for triglyceride markers, but their quantities aren't clear.
Conflicts
No caffeine, stimulant, or high-sodium conflict trigger is identified in the supplied facts.
Effective doses
Neither active omega-3 has a stated amount to compare with its dose reference.
Impact
Situational effect
Fish Oil · 2400 mg
Impact
High effect
Omega-3 · 720 mg
Omega-3 receives recognition for the skin barrier in the saved calculation. Human UV-challenge findings used a specific purified EPA preparation, so the declared generic omega-3 amount does not establish the same exposure or routine skin improvement. Fish-oil or total fatty-acid amounts cannot resolve that preparation distinction, and disease-specific skin findings do not transfer to this product.
How this product is rated for Skin Health
Ingredient fit71
The formula’s skin focus and disclosed amounts receive recognition, with the amount and preparation limitations described below.
Goal fit
The formula includes recognized skin-related ingredients alongside actives aimed at other goals, reducing its skin focus.
Dose adequacy
The recognized ingredients receive partial amount recognition; smaller or unresolved quantities limit the contribution assigned to the serving.
Pathways41
The assigned coverage is concentrated in the mechanisms below and does not establish benefit across every aspect of skin health.
Depth
The strongest assigned contribution concerns epidermal barrier lipids; this reflects the saved findings rather than a confirmed clinical effect.
Breadth
Only one evaluated mechanism reaches the coverage threshold, leaving the other aspects of skin support limited.
Evidence78
The saved evidence findings recognize the ingredients below, while the supplied scientific context limits expectations for routine skin improvement.
Evidence strength
Omega-3 supplies the leading recognized evidence contribution, although ingredient context limits what skin benefits can be expected.
Studied preparation
The saved calculation recognizes the counted preparations as studied; ingredient-specific context still limits transfer to routine skin improvement.
Formulation logic100
The counted ingredients have no unmet partner requirement or identified configured conflict. Their minimum amount findings are separate from proof of clinical benefit.
Partner coverage
The counted ingredients have no unmet partner requirement in the saved findings; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this finding does not assess overall safety or personal suitability.
Effective doses
All counted ingredients clear the saved minimum amount threshold; passing it does not make each amount a proven effective skin dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 25 Calorie(s) | |
Total Fat | 3 Gram(s) | |
Saturated Fat | 1 Gram(s) | |
Cholesterol | 15 mg | |
Fish Oil | 2400 mg | |
Total Omega-3 Fatty Acids | 720 mg | |
Eicosapentaenoic Acid | 0 NP | |
Docosahexaenoic Acid | 0 NP | |
Other Fatty Acids | 0 NP |
Omega-3 · 720 mg OverallScore46
Fish Oil · 2400 mg OverallScore24
Each serving contains 2,400 mg of fish oil identified as triglyceride, but the EPA and DHA amounts are unknown in the saved facts. That limits direct comparisons of active omega-3 content.
How this ingredient is rated
Active Ingredient Quality & Bioavailability50
The fish oil is identified as triglyceride; no purification process or independent testing is established in the saved facts.
Omega-3 Molecular Form
The evaluation identifies the fish oil as triglyceride form.
Purification & Filtration Method
No oil purification process is established in the saved facts.
Third-Party Purity & Potency Verification
The saved facts do not establish an independent testing or certification claim for the oil.
Source & Sustainability
The evaluation recognizes a fish source, but the saved facts do not identify the species or establish a sustainability certification.
Dose, Safety & Label Transparency10
A serving contains 2,400 mg of fish oil, but the saved facts do not establish its EPA and DHA amounts or their proportion of the oil. A qualifying antioxidant is included.
Total Active Omega-3 Dose (EPA + DHA)
The saved facts do not establish the EPA and DHA amounts for this serving, so their combined amount is unknown.
Omega-3 Potency & Concentration
The proportion of fish oil made up of EPA and DHA cannot be determined without their amounts.
EPA & DHA Individual Disclosure
The saved facts do not establish individual EPA and DHA milligram amounts for this serving.
Oxidation Protection (Stabilizers)
The saved facts indicate a qualifying antioxidant is included, though they do not identify it.
Value0
A cost per gram of EPA and DHA cannot be determined from the saved active-amount data.
Cost Per Gram of Active EPA + DHA
A cost per gram of EPA and DHA cannot be determined from the saved active-amount data.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Dietetic intervention in psoriatic arthritis: the DIETA trial.
- Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
- Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
- Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
- Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.